CompletedNCT00602394
Bioequivalency Study of 300 mg Lithium Carbonate Under Fed Conditions
Medication studyAges 18–38United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 38 years.
- Listed locations
- HoustonSee all locations and recruitment
Study information
Study start dateMay 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Roxane Laboratories
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 38 Years
- Official registry ID
- NCT00602394
- Official title
Show the full official title
A Single Dose, Two-Period, Two-Treatment Crossover Bioequivalency Study of 300 mg Lithium Carbonate Extended Release Tablets Under Fed Conditions
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Roxane Laboratories, a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including lithium.
Who was this study for?
Listed age limits: 18 years to 38 years.
